Literature DB >> 7584073

Gene transfer technologies for the gene therapy of cancer.

R Vile1, S J Russell.   

Abstract

Gene therapy for cancer relies upon the delivery of a therapeutic gene to a target cell population which may comprise either the tumour cells themselves or specific host effector cells with anti-tumour activity. In addition, gene delivery may be targeted directly to the tumour cells in vivo or towards cells explanted from the patient. The precise requirements of the delivery system depend upon the specific therapeutic strategy being used. In each case, however, delivery must be accurate, efficient and must result in correctly regulated expression of the gene in only the desired cell type. Equally important, the delivery system must be safe for both the patient and the community as a whole. Here, we summarize the types of gene therapy which have been proposed for the treatment of cancer and review how currently available delivery systems are suited to each of these individual strategies.

Entities:  

Mesh:

Year:  1994        PMID: 7584073

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  12 in total

1.  Glyco-poly-l-lysine is better than liposomal delivery of exogenous genes to rat of liver.

Authors:  Chang-Qing Yang; Ji-Yao Wang; Bo-Ming He; Jian-Jun Liu; Jin-Sheng Guo
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  Excision of specific DNA-sequences from integrated retroviral vectors via site-specific recombination.

Authors:  J Bergemann; K Kühlcke; B Fehse; I Ratz; W Ostertag; H Lother
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

Review 3.  Retroviral vectors. From laboratory tools to molecular medicine.

Authors:  R G Vile; A Tuszynski; S Castleden
Journal:  Mol Biotechnol       Date:  1996-04       Impact factor: 2.695

Review 4.  New therapeutic approaches based on gene transfer techniques.

Authors:  H Chong; R G Vile
Journal:  Springer Semin Immunopathol       Date:  1996

Review 5.  Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.

Authors:  R G Vile; H Chong
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 6.  Gene therapy for cancer--in the dock, blown off course or full speed ahead?

Authors:  R C Vile
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 7.  Gene therapy for cancer, the course ahead.

Authors:  R G Vile
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 8.  Molecular chemotherapy for breast cancer.

Authors:  A Patterson; A L Harris
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

9.  A comparison between intravenous and peritoneal route on liver targeted uptake and expression of plasmid delivered by Glyco-poly-l-lysine.

Authors:  Chang-Qing Yang; Ji-Yao Wang; Guo-Ting Fang; Jian-Jun Liu; Jin-Sheng Guo
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

10.  Can immunotherapy by gene transfer tip the balance against colorectal cancer?

Authors:  S M Todryk; H Chong; R G Vile; H Pandha; N R Lemoine
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.